1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,117 | 0,141 | 12:57 | |
| 0,120 | 0,139 | 12:07 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:18 | Brii Bio reports mixed results from hepatitis B studies | 3 | Investing.com | ||
| 02:00 | Brii Biosciences Limited: Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B | 21 | PR Newswire | End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses... ► Artikel lesen | |
| 00:56 | BRII-B (02137): INSIDE INFORMATION ANNOUNCES TOPLINE END-OF-TREATMENT DATA FROM PHASE 2B ENRICH AND ENHANCE STUDIES FOR THE TREATMENT OF CHRONIC HEPATITIS ... | 1 | HKEx | ||
| 18.06. | BRII-B Plans Share Buyback of Up to HKD60M | 1 | AASTOCKS | ||
| 17.06. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT SHARE BUY-BACK PROGRAMME | - | HKEx | ||
| 16.06. | BRII-B (02137): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 16, 2026 | - | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 22.05. | BRII-B (02137): INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS | 3 | HKEx | ||
| 23.04. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.04. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 23.04. | BRII-B (02137): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 1 | HKEx | ||
| 23.04. | BRII-B (02137): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | BRII-B (02137): (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT ... | - | HKEx | ||
| 23.04. | BRII-B (02137): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | BRII-B (02137): 2025 ANNUAL REPORT | - | HKEx | ||
| 16.04. | BRII-B (02137): INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS | 2 | HKEx | ||
| 19.03. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results | 409 | PR Newswire | Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts
Increasing Discovery Efforts to Drive Long-term Value Creation
Strong Cash Position Supporting Strategic... ► Artikel lesen | |
| 19.03. | BRII-B (02137): NOTIFICATION OF 2025 PFIC STATUS | - | HKEx | ||
| 19.03. | BRII-B (02137): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx | ||
| 09.03. | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
| 21.08.25 | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 225 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 189,32 | +0,12 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 03.07.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| ILLUMINA | 163,98 | -0,64 % | Piper Sandler raises Illumina stock price target on clinical strength | ||
| NANOREPRO | 2,070 | +5,61 % | NanoRepro: Attraktive Positionierung | Nach Darstellung der Analysten Matthias Greiffenberger und Cosmin Filker von GBC hat die NanoRepro AG die bisherige europäische Vertriebs- und Lizenzvereinbarung für das FiberSense-CGM-System in eine... ► Artikel lesen | |
| CYTODYN | 0,198 | +3,12 % | CytoDyn Inc.: CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer's Disease | Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the age of 50 with early-stage, biomarker-confirmed Alzheimer's disease VANCOUVER, Washington, June 11... ► Artikel lesen | |
| IMMUNIC | 12,410 | -3,84 % | IMMUNIC, INC. - 8-K, Current Report | ||
| ADAPTIVE BIOTECHNOLOGIES | 19,500 | +5,23 % | Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses | SEATTLE, June 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company focused on translating the genetics of the adaptive immune... ► Artikel lesen | |
| GENPREX | 0,557 | -3,33 % | Genprex, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| PERSONALIS | 11,910 | 0,00 % | Personalis, Inc.: Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits | Regulatory milestone for specimen collection kits enables global deployment of Personalis' ultrasensitive MRD detection (Next Personal) for drug development programs
Personalis, Inc. (Nasdaq: PSNL)... ► Artikel lesen | |
| VITROLIFE | 8,260 | -0,30 % | Vitrolife AB (publ): Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement | GOTHENBURG, Sweden, June 1, 2026 /PRNewswire/ -- Vitrolife Group today announces the appointment of Olivier Desmarets as Chief Operations Officer (COO), effective... ► Artikel lesen | |
| PLURI | 4,660 | -100,00 % | Pluri Inc.: Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement | HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. ("Pluri" or the "Company") (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based platform across multiple commercial... ► Artikel lesen | |
| LEGEND BIOTECH | 26,200 | 0,00 % | Legend Biotech Corporation: Legend Biotech Corporation Announces Pricing of Public Offering | BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced the pricing of... ► Artikel lesen | |
| ENVERIC BIOSCIENCES | 1,450 | 0,00 % | Morning Market Movers: Huachen AI Parking, FatPipe, Enveric Biosciences, Akanda See Big Swings | TEL AVIV (dpa-AFX) - At 8:00 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ENANTA | 13,200 | 0,00 % | Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals' Partner AbbVie Receives European Commission Approval of MAVIRET (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus | MAVIRET (Glecaprevir/Pibrentasvir) is the Only Treatment Approved in the European Union for Both Acute and Chronic Hepatitis C Virus (HCV) Infection Approval Allows Providers to Treat HCV... ► Artikel lesen | |
| NATURAL ALTERNATIVES INTERNATIONAL | 2,000 | 0,00 % | Natural Alternatives International Inc: Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements... ► Artikel lesen | |
| MONOPAR THERAPEUTICS | 87,80 | +2,69 % | Monopar Therapeutics Inc.: Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease | WILMETTE, Ill., June 30, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar" or the "Company") (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments... ► Artikel lesen |
BRII BIOSCIENCES LTD gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell +20,81 % bei einem Aktienkurs von 0,119 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.